查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701394

基因靜默市場規模、佔有率、趨勢分析報告：按應用、產品/服務、最終用途、地區、細分市場預測，2025-2030

Gene Silencing Market Size, Share & Trends Analysis Report By Application (Drug Discovery & Development, Therapeutics Manufacturing), By Product & Service, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

基因靜默市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球基因靜默市場規模預計到2030年將達到212.9億美元，2025年至2030年的複合年成長率為13.8%。

由於人們對遺傳疾病的認知不斷提高以及治療方法，市場正在經歷顯著成長。近年來， RNA干擾（RNAi）、反義寡核苷酸（ASO）和基於CRISPR的方法等基因靜默技術的進步，為治療以前無法治癒的遺傳疾病帶來了突破。隨著研究的進展，製藥和生物技術公司正在投入大量資源開發基因靜默療法，以滿足患有亨廷頓氏舞蹈症、肌肉萎縮症和罕見癌症等遺傳疾病的患者未滿足的醫療需求。對此類創新標靶治療藥物的需求不斷成長是市場的主要驅動力。

COVID-19 疫情為許多方面帶來了破壞性影響，但也凸顯了基因治療的重要性，並加速了基因靜默技術的發展。疫情期間，研究機構和製藥公司之間資金投入和合作的增加，活性化了疫苗技術的快速發展，並凸顯了基因靜默策略在治療多種疾病的潛力。此外，疫情也增加了人們對基因研究和藥物發現創新的關注，刺激了病毒感染、癌症治療和自體免疫疾病等領域對基因靜默方案的需求。因此，基因靜默技術受到關注，並定位為未來精準醫療的重要組成部分。

此外，基因靜默相關服務的日益普及也推動了市場擴張。受託研究機構（CRO）和契約製造組織（CMO）已成為生物技術和製藥公司開發基因靜默療法的重要合作夥伴。這些服務供應商提供臨床試驗、法規遵循和可擴展製造方面的專業知識，使基於基因靜默的藥物開發更快、更具成本效益。這場大流行凸顯了對強大、可擴展生產系統的需求，進一步推動了對支持基因治療開發的服務的需求。隨著基因靜默產品線的擴大以及公司努力滿足對這些先進治療方案日益成長的需求，預計這一趨勢將持續下去。

基因靜默市場報告重點

  • 根據產品/服務，預計服務成長最快，預測期內複合年成長率為 14.2%。基因靜默技術的複雜性增加了對臨床試驗管理、監管指導和生物資訊分析方面專家支持的需求。對此類客製化解決方案和端到端服務的需求不斷成長，推動了市場的擴張。
  • 根據應用，藥物發現和開發領域佔據了市場主導地位，在 2024 年佔據了最大的收入佔有率。高通量篩檢、生物資訊學工具和基因組資料庫的進步有望增強目標識別和檢驗過程，從而推動全球市場的成長。
  • 根據最終用途，製藥和生物技術公司將主導市場，佔據 2024 年最大的收益佔有率。這個市場受到對精準醫療日益成長的關注以及基因治療方法在治療多種遺傳疾病、癌症和罕見疾病方面的潛力的推動。
  • 2024 年，北美佔最大佔有率，為 48.23%。該地區人口極易患罕見疾病，市場滲透率不斷提高，醫療保健基礎設施技術先進，這些因素支持該地區的成長。
  • 一些主要的市場參與者包括 Revvity, Inc.、Danaher、Agilent Technologies、GenScript、Merck KGaA、Thermo Fisher Scientific, Inc.、Illumina、Bio-Rad Laboratories、Bio-Techne 和 New England Biolabs, Inc.

目錄

第1章調查方法與範圍

第2章執行摘要

第3章基因靜默市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 基因靜默市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章基因靜默市場：依產品和服務的估計和趨勢分析

  • 產品/服務細分儀表板
  • 全球基因靜默市場（按產品和服務）波動分析
  • 全球基因靜默市場規模及趨勢分析（依產品/服務，2018-2030）
  • 產品
    • RNAi
    • CRISPR-Cas9
    • 反義寡核苷酸
    • 其他
  • 服務

第5章基因靜默市場：按應用的估計和趨勢分析

  • 應用程式細分儀表板
  • 全球基因靜默市場趨勢分析（按應用）
  • 全球基因靜默市場規模及趨勢分析（依應用，2018-2030）
  • 藥物研發
    • 神經病學
    • 腫瘤學
    • 感染疾病
    • 代謝紊亂
    • 其他
  • 藥品製造
  • 農業用途
  • 其他

第6章基因靜默市場：依最終用途的估計和趨勢分析

  • 最終用途細分儀表板
  • 全球基因靜默市場趨勢分析（依最終用途）
  • 全球基因靜默市場規模及趨勢分析（依最終用途分類）（2018-2030）
  • 製藥和生物技術公司
  • 學術研究所
  • CRO 和 CMO
  • 其他

第7章基因靜默市場：區域應用評估與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域使用市場儀表板
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭格局

  • 參與企業
  • 2024年企業市場分析
  • 戰略地圖
  • 參與企業概況及簡介
    • Revvity, Inc.
    • Danaher
    • Agilent Technologies
    • GenScript
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Illumina
    • Bio-Rad Laboratories
    • Bio-Techne
    • New England Biolabs, Inc.
Product Code: GVR-4-68040-544-0

Gene Silencing Market Growth & Trends:

The global gene silencing market size is expected to reach USD 21.29 billion by 2030 and is expected to grow at 13.8% CAGR from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth due to increasing recognition of genetic disorders and urgent need for effective therapies. Over the past few years, advancements in gene silencing technologies, including RNA interference (RNAi), antisense oligonucleotides (ASOs), and CRISPR-based approaches, have led to breakthroughs in treating previously untreatable genetic diseases. As research intensifies, pharmaceutical and biotechnology companies are allocating more resources to developing gene silencing therapies to address the unmet medical needs of patients suffering from genetic conditions such as Huntington's disease, muscular dystrophy, and rare cancers. This growing demand for innovative, targeted therapies is a key driver for the market.

The COVID-19 pandemic, while disruptive in many areas, also highlighted the importance of gene-based therapies and accelerated the development of gene silencing technologies. During the pandemic, increased funding and collaboration between research institutions and pharmaceutical companies led to the rapid development of vaccine technologies, highlighting the potential of gene silencing strategies for tackling a wide range of diseases. In addition, the pandemic led to a greater focus on genetic research and innovation in drug discovery, driving the need for gene silencing solutions in areas such as viral infections, cancer treatment, and autoimmune disorders. As a result, gene silencing technologies have garnered more attention, positioning them as a critical component in the future of precision medicine.

Furthermore, the growing availability of gene silencing-related services has fueled market expansion. Contract research organizations (CROs) and contract manufacturing organizations (CMOs) have become integral partners for biotech and pharmaceutical companies developing gene silencing therapies. These service providers offer expertise in clinical trials, regulatory compliance, and scalable manufacturing, enabling faster and more cost-effective development of gene silencing-based drugs. The pandemic underscored the need for robust and scalable production systems, driving further demand for services that support gene therapy development. This trend is expected to continue as the pipeline for gene silencing products expands and as companies work to meet the increasing demand for these advanced therapeutic options.

Gene Silencing Market Report Highlights:

  • By product & service, services is expected to witness the fastest growth with a CAGR of 14.2% during the forecast period. The complexity of gene silencing techniques has created a need for expert support in clinical trial management, regulatory guidance, and bioinformatics analysis. This rising demand for customized solutions and end-to-end services is fueling market expansion
  • By application, the drug discovery & development segment dominated the market and captured the largest revenue share in 2024. Advances in high-throughput screening, bioinformatics tools, and genomic databases have enhanced target identification and validation processes and are expected to fuel global market growth
  • By end use, the pharmaceutical & biotechnology companies segment dominated the market and accounted for the largest revenue share in 2024. The market is driven by the increasing focus on precision medicine and the potential of gene-based therapies to treat a wide range of genetic disorders, cancers, and rare diseases
  • North America held the largest share of 48.23% in 2024. The presence of a population with high susceptibility to rare diseases, increased market penetration rates, and technologically advanced healthcare infrastructure support the region's growth
  • A few of the key market players include Revvity, Inc., Danaher, Agilent Technologies, GenScript, Merck KGaA, Thermo Fisher Scientific, Inc., Illumina, Bio-Rad Laboratories, Bio-Techne, New England Biolabs, Inc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Gene Silencing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising Prevalence of Genetic Disorders
      • 3.2.1.2. Technological Advancements in Delivery Systems
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Development Costs and Complex Manufacturing
      • 3.2.2.2. Regulatory and Ethical Challenges
  • 3.3. Gene Silencing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Gene Silencing Market: Product & Service Estimates & Trend Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global Gene Silencing Market Product & Service Movement Analysis
  • 4.3. Global Gene Silencing Market Size & Trend Analysis, by Product & Service, 2018 - 2030 (USD Million)
  • 4.4. Products
  • 4.5. Products Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
    • 4.5.1. RNAi
      • 4.5.1.1. RNAi Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.1.2. miRNA
        • 4.5.1.2.1. miRNA Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.1.3. siRNA
        • 4.5.1.3.1. siRNA Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.1.4. Others
      • 4.5.1.5. Others Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.2. CRISPR-Cas9
      • 4.5.2.1. CRISPR-Cas9 Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.2.2. CRISPR Kits & Reagents
        • 4.5.2.2.1. CRISPR Kits & Reagents Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.2.3. CRISPR Libraries
        • 4.5.2.3.1. CRISPR Libraries Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.2.4. Others
      • 4.5.2.5. Others Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.3. Antisense Oligonucleotides
      • 4.5.3.1. Antisense Oligonucleotides Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)

Chapter 5. Gene Silencing Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Gene Silencing Market Application Movement Analysis
  • 5.3. Global Gene Silencing Market Size & Trend Analysis, by Application, 2018 - 2030 (USD Million)
  • 5.4. Drug Discovery & Development
  • 5.5. Drug Discovery & Development Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
    • 5.5.1. Neurology
      • 5.5.1.1. Neurology Market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.5.2. Oncology
      • 5.5.2.1. Oncology Market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.5.3. Infectious Diseases
      • 5.5.3.1. Infectious Diseases Market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.5.4. Metabolic Diseases
      • 5.5.4.1. Metabolic Diseases Market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.5.5. Others
      • 5.5.5.1. Others Market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.6. Therapeutics Manufacturing
    • 5.6.1. Therapeutics Manufacturing Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
  • 5.7. Agricultural Applications
    • 5.7.1. Agricultural Applications Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)

Chapter 6. Gene Silencing Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Gene Silencing Market End Use Movement Analysis
  • 6.3. Global Gene Silencing Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & Research Institutes Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
  • 6.6. CROs & CMOs
    • 6.6.1. CROs & CMOs Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)

Chapter 7. Gene Silencing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Strategy Mapping
  • 8.4. Participants Overview
    • 8.4.1. Revvity, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Danaher
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Agilent Technologies
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. GenScript
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Merck KGaA
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Thermo Fisher Scientific, Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Illumina
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Bio-Rad Laboratories
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Bio-Techne
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. New England Biolabs, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
  • Table 3 North America Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 4 North America Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 North America Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 7 U.S. Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 9 Canada Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 10 Canada Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 Canada Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Mexico Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 13 Mexico Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 14 Mexico Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15 Europe Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
  • Table 16 Europe Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 17 Europe Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 18 Europe Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 UK Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 20 UK Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 21 UK Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 22 Germany Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 23 Germany Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Germany Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Italy Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 26 Italy Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 27 Italy Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 28 France Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 29 France Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 France Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Spain Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 32 Spain Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Spain Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 Sweden Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 35 Sweden Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 Sweden Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Denmark Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 38 Denmark Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 40 Norway Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 41 Norway Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 42 Norway Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 47 China Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 48 China Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 China Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 Japan Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 51 Japan Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Japan Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 India Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 54 India Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 India Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 56 South Korea Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 57 South Korea Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 59 Australia Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 60 Australia Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 61 Australia Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Thailand Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 63 Thailand Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 64 Thailand Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 65 Latin America Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
  • Table 66 Latin America Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 67 Latin America Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 68 Latin America Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Brazil Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 70 Brazil Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 71 Brazil Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 73 Argentina Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Argentina Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 Middle East Africa Gene Silencing Market, by Region, 2018 - 2030 (USD Million)
  • Table 76 Middle East Africa Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 77 Middle East Africa Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 Middle East Africa Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 80 South Africa Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 South Africa Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 85 UAE Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 86 UAE Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 UAE Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Gene Silencing Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Gene Silencing Market, by Application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Gene Silencing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value-Chain-Based Sizing & Forecasting
  • Fig. 6 QFD Modeling for Market Share Assessment
  • Fig. 7 Market formulation & Validation
  • Fig. 8 Gene Silencing Market: Market Outlook
  • Fig. 9 Parent Market Outlook
  • Fig. 10 Related/Ancillary Market Outlook
  • Fig. 11 Penetration and Growth Prospect Mapping
  • Fig. 12 Industry Value Chain Analysis
  • Fig. 13 Gene Silencing Market Driver Impact
  • Fig. 14 Gene Silencing Market Restraint Impact
  • Fig. 15 Gene Silencing Market Strategic Initiatives Analysis
  • Fig. 16 Gene Silencing Market: Product & Service Movement Analysis
  • Fig. 17 Gene Silencing Market: Product & Service Outlook and Key Takeaways
  • Fig. 18 Products Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 19 RNAi Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 20 miRNA Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 21 siRNA Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 23 CRISPR-Cas9 Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 24 CRISPR Kits & Reagents Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 25 CRISPR Libraries Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Others Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Antisense Oligonucleotides Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Others Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Services Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Gene Silencing Market: Application Movement Analysis
  • Fig. 31 Gene Silencing Market: Application Outlook and Key Takeaways
  • Fig. 32 Drug Discovery & Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Metabolic Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Therapeutics Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Agricultural Applications Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Gene Silencing Market: End-Use Movement Analysis
  • Fig. 42 Gene Silencing Market: End-Use Outlook and Key Takeaways
  • Fig. 43 Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 CROs & CMOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Global Gene Silencing Market: Regional Movement Analysis
  • Fig. 48 Global Gene Silencing Market: Regional Outlook and Key Takeaways
  • Fig. 49 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 U.S. Country Dynamics
  • Fig. 51 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Canada Country Dynamics
  • Fig. 53 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico Country Dynamics
  • Fig. 55 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 UK Country Dynamics
  • Fig. 58 UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Germany Country Dynamics
  • Fig. 60 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 France Country Dynamics
  • Fig. 62 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Italy Country Dynamics
  • Fig. 64 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Spain Country Dynamics
  • Fig. 66 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Denmark Country Dynamics
  • Fig. 68 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Sweden Country Dynamics
  • Fig. 70 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Norway Country Dynamics
  • Fig. 72 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 China Country Dynamics
  • Fig. 75 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Japan Country Dynamics
  • Fig. 77 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 India Country Dynamics
  • Fig. 79 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Thailand Country Dynamics
  • Fig. 81 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 South Korea Country Dynamics
  • Fig. 83 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Australia Country Dynamics
  • Fig. 85 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Brazil Country Dynamics
  • Fig. 88 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Argentina Country Dynamics
  • Fig. 90 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 South Africa Country Dynamics
  • Fig. 93 South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Saudi Arabia Country Dynamics
  • Fig. 95 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 UAE Country Dynamics
  • Fig. 97 UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Kuwait Country Dynamics
  • Fig. 99 Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Market Position of Key Market Players